These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 38043648)
21. Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease. Cohen AD; Landau SM; Snitz BE; Klunk WE; Blennow K; Zetterberg H Mol Cell Neurosci; 2019 Jun; 97():3-17. PubMed ID: 30537535 [TBL] [Abstract][Full Text] [Related]
22. Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport. Sherman MA; LaCroix M; Amar F; Larson ME; Forster C; Aguzzi A; Bennett DA; Ramsden M; Lesné SE J Neurosci; 2016 Sep; 36(37):9647-58. PubMed ID: 27629715 [TBL] [Abstract][Full Text] [Related]
23. Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy. Xin SH; Tan L; Cao X; Yu JT; Tan L Neurotox Res; 2018 Oct; 34(3):733-748. PubMed ID: 29626319 [TBL] [Abstract][Full Text] [Related]
24. Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease. Zhang H; Wei W; Zhao M; Ma L; Jiang X; Pei H; Cao Y; Li H Int J Biol Sci; 2021; 17(9):2181-2192. PubMed ID: 34239348 [TBL] [Abstract][Full Text] [Related]
25. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease. Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675 [TBL] [Abstract][Full Text] [Related]
26. Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer's disease. Shah TM; Gupta SM; Chatterjee P; Campbell M; Martins RN Mol Psychiatry; 2017 Mar; 22(3):353-363. PubMed ID: 28093567 [TBL] [Abstract][Full Text] [Related]
27. Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. Tran HT; LaFerla FM; Holtzman DM; Brody DL J Neurosci; 2011 Jun; 31(26):9513-25. PubMed ID: 21715616 [TBL] [Abstract][Full Text] [Related]
28. Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease. Gong B; Ji W; Chen X; Li P; Cheng W; Zhao Y; He B; Zhuang J; Gao J; Yin Y Mini Rev Med Chem; 2022; 22(17):2260-2270. PubMed ID: 35156576 [TBL] [Abstract][Full Text] [Related]
29. From Small Peptides to Large Proteins against Alzheimer'sDisease. Picone P; Sanfilippo T; Vasto S; Baldassano S; Guggino R; Nuzzo D; Bulone D; San Biagio PL; Muscolino E; Monastero R; Dispenza C; Giacomazza D Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291553 [TBL] [Abstract][Full Text] [Related]
30. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease. Wang P; Wang ZY Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171 [TBL] [Abstract][Full Text] [Related]
31. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease. Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903 [TBL] [Abstract][Full Text] [Related]
32. A Recent Update on Pathophysiology and Therapeutic Interventions of Alzheimer's Disease. Kashif M; Sivaprakasam P; Vijendra P; Waseem M; Pandurangan AK Curr Pharm Des; 2023; 29(43):3428-3441. PubMed ID: 38038007 [TBL] [Abstract][Full Text] [Related]
33. Co-Localization of Glia Maturation Factor with NLRP3 Inflammasome and Autophagosome Markers in Human Alzheimer's Disease Brain. Ahmed ME; Iyer S; Thangavel R; Kempuraj D; Selvakumar GP; Raikwar SP; Zaheer S; Zaheer A J Alzheimers Dis; 2017; 60(3):1143-1160. PubMed ID: 28984607 [TBL] [Abstract][Full Text] [Related]
34. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation. Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397 [TBL] [Abstract][Full Text] [Related]
35. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182 [TBL] [Abstract][Full Text] [Related]
36. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
37. Role of TREM2 in Alzheimer's Disease and its Consequences on β- Amyloid, Tau and Neurofibrillary Tangles. Singh AK; Mishra G; Maurya A; Awasthi R; Kumari K; Thakur A; Rai A; Rai GK; Sharma B; Kulkarni GT; Singh SK Curr Alzheimer Res; 2019; 16(13):1216-1229. PubMed ID: 31481003 [TBL] [Abstract][Full Text] [Related]
38. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease. Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998 [TBL] [Abstract][Full Text] [Related]